Saturday, March 30, 2024
9:30 AM – 2:30 PM (breakfast and lunch will be provided)
University of Tennessee Health Science Center (UTHSC)
Mooney Building Library, Room 201
875 Monroe Avenue
Memphis, TN 38163
Activity Overview: The 2024 Annual Updates in Hematology Symposium is designed to provide hematology and oncology providers with a state-of-the-art update on hematologic malignancies and blood disorders. It will tackle the latest scientific updates, innovative ideas, and timeliest questions related to the management and care of these challenging conditions. It is also designed to provide a networking opportunity for healthcare professionals, who care for patients with blood cancers and disorders in the Mid-South, to establish collaborative pathways to improve the management and outcomes of this patient population.
Educational Objectives:
· Identify guidelines to plan and implement individualized treatment decisions for patients with select blood cancers and disorders by leveraging data from molecular and genetic updates.
· Evaluate the latest evidence-based data from clinical trials for emerging therapeutic strategies for select blood cancers and disorders.
· Discuss best strategies in managing treatment-related adverse events through agent familiarity and robust monitoring efforts.
Target Audience: Primary care physicians, hematologists, pathologists, medical oncologists, nurse practitioners, fellows, residents, medical students, and other healthcare professionals dedicated to treating blood cancers and disorders.
Here is a brochure that includes the agenda.
Disclosure Statement:
The University of Tennessee College of Medicine is committed to providing CME that is balanced, objective, and evidence based.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Essentials and Standards, all parties involved in content development are required to disclose any real or apparent conflicts of interest relating to the topics of this educational activity.
The University of Tennessee College of Medicine has established mechanisms to resolve conflicts of interest should they arise. Any potential conflict of interest or off label use will be disclosed to the audience prior to the activity.
3.25 CME / CEU credits provided
AMA Credit Designation: The University of Tennessee College of Medicine (UTCOM) designates this live activity for a maximum of 3.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education for Non-Physicians: The UTCOM will issue Certificates of Participation to non-physicians for participating in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded .1 CEU.
Accreditation: The UTCOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Registration:
There is no cost to attend this symposium. However, space is limited.
Registration is available at: https://cenow.uthsc.edu/content/2024-hematology-symposium